126 related articles for article (PubMed ID: 8662778)
21. SHP-1 expression in peripheral T cells from patients with Sezary syndrome and in the T cell line HUT-78: implications in JAK3-mediated signaling.
León F; Cespón C; Franco A; Lombardía M; Roldán E; Escribano L; Harto A; González-Porqué P; Roy G
Leukemia; 2002 Aug; 16(8):1470-7. PubMed ID: 12145687
[TBL] [Abstract][Full Text] [Related]
22. Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities.
Losdyck E; Hornakova T; Springuel L; Degryse S; Gielen O; Cools J; Constantinescu SN; Flex E; Tartaglia M; Renauld JC; Knoops L
J Biol Chem; 2015 Nov; 290(48):29022-34. PubMed ID: 26446793
[TBL] [Abstract][Full Text] [Related]
23. Expression pattern of fibroblast growth factors (FGFs), their receptors and antagonists in primary endothelial cells and vascular smooth muscle cells.
Antoine M; Wirz W; Tag CG; Mavituna M; Emans N; Korff T; Stoldt V; Gressner AM; Kiefer P
Growth Factors; 2005 Jun; 23(2):87-95. PubMed ID: 16019430
[TBL] [Abstract][Full Text] [Related]
24. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells.
Lin Q; Lai R; Chirieac LR; Li C; Thomazy VA; Grammatikakis I; Rassidakis GZ; Zhang W; Fujio Y; Kunisada K; Hamilton SR; Amin HM
Am J Pathol; 2005 Oct; 167(4):969-80. PubMed ID: 16192633
[TBL] [Abstract][Full Text] [Related]
25. Nonhematopoietic expression of Janus kinase 3 is required for efficient recruitment of Th2 lymphocytes and eosinophils in OVA-induced airway inflammation.
Verbsky JW; Randolph DA; Shornick LP; Chaplin DD
J Immunol; 2002 Mar; 168(5):2475-82. PubMed ID: 11859141
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-13 is a potent activator of JAK3 and STAT6 in cells expressing interleukin-2 receptor-gamma and interleukin-4 receptor-alpha.
Malabarba MG; Rui H; Deutsch HH; Chung J; Kalthoff FS; Farrar WL; Kirken RA
Biochem J; 1996 Nov; 319 ( Pt 3)(Pt 3):865-72. PubMed ID: 8920992
[TBL] [Abstract][Full Text] [Related]
27. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
[TBL] [Abstract][Full Text] [Related]
28. Regulation of JAK3 expression and activation in human B cells and B cell malignancies.
Tortolani PJ; Lal BK; Riva A; Johnston JA; Chen YQ; Reaman GH; Beckwith M; Longo D; Ortaldo JR; Bhatia K; McGrath I; Kehrl J; Tuscano J; McVicar DW; O'Shea JJ
J Immunol; 1995 Dec; 155(11):5220-6. PubMed ID: 7594533
[TBL] [Abstract][Full Text] [Related]
29. Activation of the Jak3 pathway and myeloid differentiation.
Mangan JK; Reddy EP
Leuk Lymphoma; 2005 Jan; 46(1):21-7. PubMed ID: 15621777
[TBL] [Abstract][Full Text] [Related]
30. Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes.
Kawamura M; McVicar DW; Johnston JA; Blake TB; Chen YQ; Lal BK; Lloyd AR; Kelvin DJ; Staples JE; Ortaldo JR; O'Shea JJ
Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6374-8. PubMed ID: 8022790
[TBL] [Abstract][Full Text] [Related]
31. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
[TBL] [Abstract][Full Text] [Related]
32. Janus kinase 3: a novel target for selective transplant immunosupression.
Podder H; Kahan BD
Expert Opin Ther Targets; 2004 Dec; 8(6):613-29. PubMed ID: 15584866
[TBL] [Abstract][Full Text] [Related]
33. Molecular analysis of the IL-2 receptor beta chain gene expressed in human tumor cells.
Suminami Y; Kashii Y; Law JC; Lin WC; Stanson J; Reichert TE; Rabinowich H; Whiteside TL
Oncogene; 1998 Mar; 16(10):1309-17. PubMed ID: 9546432
[TBL] [Abstract][Full Text] [Related]
34. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling.
Murata T; Noguchi PD; Puri RK
J Immunol; 1996 Apr; 156(8):2972-8. PubMed ID: 8609418
[TBL] [Abstract][Full Text] [Related]
35. Jak3 expression in glomerular epithelia of IgA nephropathy (IgA-N) patients.
Takahashi T; Shirasawa T; Miyake K; Yahagi Y; Matsumura O; Abe A; Natori Y; Yamabe H; Utsunomiya Y; Maruyama N; Mitarai T; Sakai O
Clin Exp Immunol; 1996 Jun; 104(3):517-24. PubMed ID: 9099938
[TBL] [Abstract][Full Text] [Related]
36. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals.
Chen M; Cheng A; Chen YQ; Hymel A; Hanson EP; Kimmel L; Minami Y; Taniguchi T; Changelian PS; O'Shea JJ
Proc Natl Acad Sci U S A; 1997 Jun; 94(13):6910-5. PubMed ID: 9192665
[TBL] [Abstract][Full Text] [Related]
37. Similarities and differences in signal transduction by interleukin 4 and interleukin 13: analysis of Janus kinase activation.
Keegan AD; Johnston JA; Tortolani PJ; McReynolds LJ; Kinzer C; O'Shea JJ; Paul WE
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7681-5. PubMed ID: 7544000
[TBL] [Abstract][Full Text] [Related]
38. JAK3 Janus kinase is involved in interleukin 7 signal pathway.
Zeng YX; Takahashi H; Shibata M; Hirokawa K
FEBS Lett; 1994 Oct; 353(3):289-93. PubMed ID: 7957877
[TBL] [Abstract][Full Text] [Related]
39. Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154.
Säemann MD; Zeyda M; Diakos C; Szekeres A; Böhmig GA; Kelemen P; Parolini O; Stockinger H; Prieschl EE; Stulnig TM; Baumruker T; Zlabinger GJ
Transplantation; 2003 Jun; 75(11):1864-72. PubMed ID: 12811247
[TBL] [Abstract][Full Text] [Related]
40. Human ovarian-carcinoma cell lines express IL-4 and IL-13 receptors: comparison between IL-4- and IL-13-induced signal transduction.
Murata T; Obiri NI; Puri RK
Int J Cancer; 1997 Jan; 70(2):230-40. PubMed ID: 9009165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
